Journal article

Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target


Authors listAllen, SM; Lim, EE; Jortzik, E; Preuss, J; Chua, HH; MacRae, JI; Rahlfs, S; Haeussler, K; Downton, MT; McConville, MJ; Becker, K; Ralph, SA

Publication year2015

Pages3808-3823

JournalThe FEBS Journal

Volume number282

Issue number19

ISSN1742-464X

eISSN1742-4658

Open access statusBronze

DOI Linkhttps://doi.org/10.1111/febs.13380

PublisherWiley


Abstract
The malarial parasite Plasmodium falciparum is exposed to substantial redox challenges during its complex life cycle. In intraerythrocytic parasites, haemoglobin breakdown is a major source of reactive oxygen species. Deficiencies in human glucose-6-phosphate dehydrogenase, the initial enzyme in the pentose phosphate pathway (PPP), lead to a disturbed redox equilibrium in infected erythrocytes and partial protection against severe malaria. In P. falciparum, the first two reactions of the PPP are catalysed by the bifunctional enzyme glucose-6-phosphate dehydrogenase 6-phospho-gluconolactonase (PfGluPho). This enzyme differs structurally from its human counterparts and represents a potential target for drugs. In the present study we used epitope tagging of endogenous PfGluPho to verify that the enzyme localises to the parasite cytosol. Furthermore, attempted double crossover disruption of the PfGluPho gene indicates that the enzyme is essential for the growth of blood stage parasites. As a further step towards targeting PfGluPho pharmacologically, ellagic acid was characterised as a potent PfGluPho inhibitor with an IC50 of 76 nM. Interestingly, pro-oxidative drugs or treatment of the parasites with H2O2 only slightly altered PfGluPho expression or activity under the conditions tested. Furthermore, metabolic profiling suggested that pro-oxidative drugs do not significantly perturb the abundance of PPP intermediates. These data indicate that PfGluPho is essential in asexual parasites, but that the oxidative arm of the PPP is not strongly regulated in response to oxidative challenge.



Authors/Editors




Citation Styles

Harvard Citation styleAllen, S., Lim, E., Jortzik, E., Preuss, J., Chua, H., MacRae, J., et al. (2015) Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target, The FEBS Journal, 282(19), pp. 3808-3823. https://doi.org/10.1111/febs.13380

APA Citation styleAllen, S., Lim, E., Jortzik, E., Preuss, J., Chua, H., MacRae, J., Rahlfs, S., Haeussler, K., Downton, M., McConville, M., Becker, K., & Ralph, S. (2015). Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target. The FEBS Journal. 282(19), 3808-3823. https://doi.org/10.1111/febs.13380


Last updated on 2025-10-06 at 10:32